SEC Form 4 · accession 0001140361-17-010118
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jon Snodgres
Officer — Chief Financial Officer
Period of report
Feb 23, 2017
Accepted (ET)
Mar 1, 2017 · 8:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2017 | A | 9,875 | $0.00 | A | 27,328 | D | |
| Common StockF2 | Mar 1, 2017 | F | 1,630 | $32.0693 | D | 25,698 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $32.32 | Feb 23, 2017 | A | 19,750 | A | — | Feb 23, 2027 | Common Stock | 19,750 | 19,750 | D |
Explanation of responses
- F1Mr. Snodgres was awarded 9,875 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2Payment of tax liability made via forfeiture of 1,630 shares of Common Stock valued at a weighted average price of $32.0693 per share on March 1, 2017.
- F3The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.